Vimarsana
Biggest News Aggregation in the World

Page 3 - Greg Berk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Berk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Berk Today - Breaking & Trending Today

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022 - Vimarsana News

GT Biopharma to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

BRISBANE, Calif., March 3, 2022 /PRNewswire/ -- GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary... | March 3, 2022

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference - Vimarsana News

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

/PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the...

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference - Vimarsana News

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing ...

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference - Vimarsana News

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural... | January 20, 2022

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference - Vimarsana News

GT Biopharma to Present at B. Riley Securities' Virtual Oncology Conference

BRISBANE, Calif., Jan. 20, 2022 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing ...